A seizure disorder is a neurological disorder characterized by abnormal electrical discharges from nerve cells in the brain, which can result in convulsions, muscle spasms, and loss of consciousness. The most common type of seizure disorder is epilepsy, which can cause repeated and prolonged seizures that significantly interfere with daily activities and can cause physical injury and death. Other types of seizure disorders include absence seizures, focal seizures, infantile spasms, juvenile myoclonic epilepsy, and Lennox-Gastaut syndrome. Epilepsy is the most common form of a seizure disorder, affecting over 16 million adults and children in the United States alone. Epilepsy is characterized by the occurrence of spontaneous, recurrent, and unprovoked seizures, which can last from seconds to minutes. Seizures can be divided into two main types -- generalized and focal. Generalized seizures involve the whole brain, while focal seizures involve just one part. Epilepsy is caused by an imbalance of nerve cells in the brain, which can be triggered by many different factors. Treatment for seizure disorders depends on the type of seizure. For epilepsy, some medications can be used to reduce the frequency and severity of seizures. Other treatments, such as the ketogenic diet, vagus nerve stimulation, and epilepsy surgery, may be recommended to help control seizures or reduce the risk of recurrence. In severe cases, where seizures are unmanageable or life-threatening, certain medical devices may be implanted, such as a vagus nerve stimulator or a responsive neurostimulator. The latter device is designed to detect seizures and then send electrical signals to the brain to prevent them from happening. In addition to medication and medical device therapies, lifestyle changes can have a positive impact on seizure disorders. These can include avoiding triggers, getting enough sleep, eating a balanced diet, and finding ways to manage stress. Overall, seizure disorders can have a serious impact on an individual's life.
Title : Novel important cellular responses, signaling mechanisms and therapeutic options in vascular dementia
Yong Xiao Wang, Albany Medical College, United States
Title : TBI updates in 2025
Jonathan Eskenazi, Cedars Sinai / UCLA, United States
Title : A case of vile vindictive primary CNS vasculitis
George Diaz, Memorial Healthcare Systems, United States
Title : Non-pharmacological strategies to counteract oxaliplatin toxicity: Protective effects of vagal nerve stimulation and resistance training on neuropathy, motor dysfunction, and muscle atrophy
Ricardo Aparecido Baptista Nucci, Hospital Sirio-Libanes, Brazil
Title : Synapticare: Integrating sleep data and tau biomarkers to assess depression severity
Medha Menon, John Foster Dulles HS, United States
Title : How have we eliminated infection: From the bone to brain?
Thomas J Webster, Interstellar Therapeutics, United States